Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Available for licensing from BTG: immune function modulator with applications in dermatology

March 5, 1999

Luxiq granted marketing clearance by the FDA

March 4, 1999

Genzyme General's Seprafilm approved in Europe for cardiac surgery

Feb. 26, 1999

MS&D launches alopecia treatment in Spain

Feb. 25, 1999

New combination product represents a highly effective approach to acne vulgaris

Feb. 23, 1999

Available for licensing from VUFB: dopamine agonist for dermatology, gastrointestinal indications

Feb. 19, 1999

Early clinical results presented for ABX-IL-8 in psoriasis

Feb. 17, 1999

Fresenius will distribute Genzyme's Sepra products in select European markets

Feb. 17, 1999

Health Canada approves first active wound-healing agent

Feb. 16, 1999

AxyS initiates phase Ib studies of APC-2059 in psoriasis

Feb. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...